A Study to Assess the Effect of Tocilizumab Plus Methotrexate on Safety and Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis.
Condition: Rheumatoid Arthritis Interventions: Drug: tocilizumab [RoActemra/Actemra]; Drug: methotrexate Sponsor: Hoffmann-La Roche Active, not recruiting - verified July 2011